Kristen E Pauken

16PUBLICATIONS
155CO-AUTHORS
AutoimmunityHaematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 05, 2026
IGF1 modulates lesional skin inflammation in checkpoint inhibitor-induced lichen planus.

|Nov 24, 2025
Bhlhe40 Coordinates T Cell Programs with Distinct CD4 and CD8 T Cell Requirements for Anti-PD-1 Versus Anti-CTLA-4.

Akata Saha, Tomoyuki Minowa, Alexander S Shavkunov

|Jul 24, 2025
PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and a cell-extrinsic fashion.

Kristen E Pauken, Samuel C Markson, Thomas S Conway

|Mar 12, 2025
In vivo antibody labeling route and fluorophore dictate labeling efficiency, sensitivity, and longevity.

Natalie B Hagan, Charles Inaku, Nikesh Kunder

|Mar 05, 2025
Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma.

Kelly M Mahuron, Osmaan Shahid, Prachi Sao

|Nov 26, 2024
Next-generation combination approaches for immune checkpoint therapy.

Sangeeta Goswami, Kristen E Pauken, Linghua Wang

Pageof 3

Frequent Collaborators

9 joint publications

Arlene H Sharpe

5 joint publications

Jason M Schenkel

4 joint publications

Osmaan Shahid

3 joint publications

Gordon J Freeman